Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 11.4 | 42.8 | 62.1 | 20.2 | 2.2 | 12.6 | 2.3 |
| Revenue growth | -73.5% | -31.1% | 207.1% | 825.7% | -82.7% | 457.3% | |
| Cost of goods sold | 8.2 | 24.5 | 55.2 | 12.0 | 1.8 | 9.9 | 1.8 |
| Gross profit | 3.1 | 18.3 | 6.9 | 8.2 | 0.3 | 2.7 | 0.5 |
| Gross margin | 27.7% | 42.7% | 11.2% | 40.6% | 16.0% | 21.2% | 20.3% |
| Selling, general and administrative | 9.1 | 9.7 | 8.2 | 5.1 | 4.4 | 3.4 | 3.8 |
| Research and development | 11.2 | 14.3 | 11.7 | 6.2 | 4.9 | 4.2 | 3.5 |
| EBIT | -17.2 | -6.1 | 7.3 | -3.1 | -8.9 | -5.5 | -7.1 |
| EBIT margin | -151.5% | -14.2% | 11.8% | -15.2% | -408.0% | -43.6% | -311.7% |
| Pre-tax income | -17.7 | -5.4 | 10.3 | 4.7 | -116.6 | -11.3 | -15.8 |
| Income taxes | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 2.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -17.7 | -5.4 | 10.1 | 4.7 | -116.6 | -11.3 | -15.8 |
| Net margin | -156.3% | -12.7% | 16.2% | 23.3% | -5334.6% | -89.5% | -695.7% |
| |
| Diluted EPS | ($1.06) | ($0.33) | $0.61 | $0.29 | ($14.77) | ($0.04) | ($0.07) |
| Shares outstanding (diluted) | 16.7 | 16.6 | 16.5 | 16.0 | 7.9 | 301.6 | 240.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|